Universitätsklinikum Schleswig-Holstein (UKSH)

Epidemiology of vulvar and vaginal cancer in Germany (2011) Dittmer C, Katalinic A, Mundhenke C, Thill M, Fischer D Journal article Trastuzumab beyond progression: Overall survival analysis of the GBG 26/BIG 3-05 phase III study in HER2-positive breast cancer (2011) Von Minckwitz G, Schweller K, Schmidt M, Barinoff J, Mundhenke C, Cufer T, Maartense E, et al. Journal article NOD2/CARD15 gene polymorphisms affect outcome in pediatric allogeneic stem cell transplantation (2011) Kreyenberg H, Jarisch A, Bayer C, Schuster B, Willasch A, Strahm B, Kremens B, et al. Journal article Research recommendations toward a better understanding of the causes of childhood leukemia (2011) Ziegelberger G, Baum C, Borkhardt A, Cobaleda C, Dasenbrock C, Dehos A, Grosche B, et al. Journal article, Original article Powerplex® ES versus Powerplex® S5 - Casework testing of the new screening kit (2011) Poetsch M, Kamphausen T, Bajanowski T, Schwark T, Von Wurmb-Schwark N Journal article Active immunization with amyloid-β 1-42 impairs memory performance through TLR2/4-dependent activation of the innate immune system (2010) Vollmar P, Kullmann JS, Thilo B, Claussen MC, Rothhammer V, Jacobi H, Sellner J, et al. Journal article Therapeutic recommendations for mammary carcinoma Therapieempfehlungen bei mammakarzinom (2010) Mundhenke C Journal article Heterogeneous expression of serine protease inhibitor maspin in ovarian cancer (2010) Bauerschlag DO, Habermann M, Weimer J, Meinhold-Heerlein I, Hilpert F, Weigel M, Bauer M, et al. Journal article Monitoring serum HER2 levels during neoadjuvant trastuzumab treatment within the GeparQuattro trial (2010) Witzel I, Loibl S, Von Minckwitz G, Mundhenke C, Huober J, Hanusch C, Henschen S, et al. Journal article Dexrazoxane (Savene) is the standard therapy for anthracycline extravasation Dexrazoxan (Savene) als Standard in der Therapie von Anthrazyklinparavasaten (2010) Mundhenke C Journal article